Previous studies have shown that over-expression of PRKCQ, a member of the novel PKC family significantly enhances growth, migration and drug resistance of breast cancer cells; furthermore, silencing of PRKCQ inhibits breast cancer cell growth by promoting apoptosis [23]. The gene discussed is PRKCQ; the disease is breast cancer.